Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Cash & Equivalents: 2014-2023

Historic Cash & Equivalents for Ocugen (OCGN) over the last 10 years, with Dec 2023 value amounting to $39.5 million.

  • Ocugen's Cash & Equivalents fell 77.76% to $15.7 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.7 million, marking a year-over-year decrease of 77.76%. This contributed to the annual value of $39.5 million for FY2023, which is 49.12% down from last year.
  • As of FY2023, Ocugen's Cash & Equivalents stood at $39.5 million, which was down 49.12% from $77.6 million recorded in FY2022.
  • Ocugen's Cash & Equivalents' 5-year high stood at $95.0 million during FY2021, with a 5-year trough of $7.4 million in FY2019.
  • In the last 3 years, Ocugen's Cash & Equivalents had a median value of $77.6 million in 2022 and averaged $70.7 million.
  • As far as peak fluctuations go, Ocugen's Cash & Equivalents surged by 357.21% in 2019, and later plummeted by 49.12% in 2023.
  • Over the past 5 years, Ocugen's Cash & Equivalents (Yearly) stood at $7.4 million in 2019, then surged by 222.93% to $24.0 million in 2020, then spiked by 295.02% to $95.0 million in 2021, then fell by 18.32% to $77.6 million in 2022, then crashed by 49.12% to $39.5 million in 2023.